(Q59390248)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18612591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Trastuzumab induces gastrointestinal side effects in HER2-overexpressing breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18612591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18612591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Rachel J. Gibson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18612591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Thomas R. Sullivan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18612591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Noor Al-Dasooqi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18612591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Jude Lees

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18612591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Dorothy M Keefe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18612591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

9 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18612591%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18612591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18612591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18612591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

173-178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18612591%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10637-008-9152-1

10 January 2020

exact match

0 references

cites work

Mucosal injury from targeted anti-cancer therapy.

1 reference

12 December 2020

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

12 December 2020

The ErbB2 signaling network as a target for breast cancer therapy

1 reference

12 December 2020

Sensitization of chemotherapy by anti-HER.

1 reference

12 December 2020

Emesis induced by low or minimal emetic risk chemotherapy

1 reference

12 December 2020

Expression, location, and interactions of ErbB2 and its intramembrane ligand Muc4 (sialomucin complex) in rat mammary gland during pregnancy

1 reference

12 December 2020

Adjuvant treatment of breast cancer: impact of monoclonal antibody therapy directed against the HER2 receptor

1 reference

12 December 2020

Colonic Epithelial Expression of ErbB2 Is Required for Postnatal Maintenance of the Enteric Nervous System

1 reference

12 December 2020

Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer

1 reference

12 December 2020

Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells

1 reference

12 December 2020

Cell signaling through membrane mucins

1 reference

12 December 2020

Pooled analysis of diarrhea events in patients with cancer treated with lapatinib

1 reference

12 December 2020

Evaluation of the elderly with cancer

1 reference

12 December 2020

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

12 December 2020

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

1 reference

12 December 2020

Mechanism of action of trastuzumab and scientific update

1 reference

12 December 2020

Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer

1 reference

12 December 2020

Establishment of a Single-Dose Irinotecan Model of Gastrointestinal Mucositis

1 reference

12 December 2020

Mucins: structure, function, and role in pulmonary diseases

1 reference

12 December 2020

Nuclear factor κB (NFκB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes

1 reference

12 December 2020

Signaling through ERBB receptors: multiple layers of diversity and control

1 reference

12 December 2020

Saccharic acid 1.4-lactone protects against CPT-11-induced mucosa damage in rats

1 reference

12 December 2020

Trastuzumab: a review of its use in the management of HER2-positive metastatic and early-stage breast cancer

1 reference

12 December 2020

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

12 December 2020

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

1 reference

12 December 2020

Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive

1 reference

12 December 2020

Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy.

1 reference

12 December 2020

Chemotherapy-induced emesis in elderly cancer patients: the role of 5-HT3-receptor antagonists in the first 24 hours

1 reference

12 December 2020

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

1 reference

12 December 2020

Relationship between dose of methotrexate, apoptosis, p53/p21 expression and intestinal crypt proliferation in the rat

1 reference

12 December 2020

Clinical trials of Herceptin(trastuzumab).

1 reference

12 December 2020

10.1007/S10637-008-9152-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18612591%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference